New Oral Drugs Approved for Drug-Resistant Gonorrhoea Treatment
The US FDA has approved two new oral medications, zoliflodacin and gepotidacin, to combat drug-resistant gonorrhoea, a critical development as antibiotic resistance threatens to make the STD untreatable globally.


